Skip to main content
Caplight Logo









Lungpacer Medical

Lungpacer Medical

Private
Exton, PennsylvaniaHealthcare & Life Scienceshttps://lungpacer.com/

Last Round

Convertible Debt

Apr 28, 2026

Total Funding Raised

$163.86M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Lungpacer Medical is a medical device company that develops minimally invasive neurostimulation technologies to help critically ill patients wean off mechanical ventilation and restore diaphragm strength.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

transvenous diaphragm neurostimulationmechanical ventilationventilator weaningphrenic nerve stimulationdiaphragm pacingintensive care unitICUventilator dependencediaphragm atrophymedical devicerespiratory supportnew technology add-on paymentNTAPcritical care technologyventilator-induced diaphragm dysfunctionVIDD

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lungpacer Medical Comparables

Compare Lungpacer Medical with similar companies based on industry and business-model similarity.

Lungpacer Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Synapse Biomedical Inc.
90%
Stimdia Medical
88%
Liberate Medical
86%

Lungpacer Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtApr 28, 2026
Growth EquityJun 26, 2025
Convertible DebtApr 1, 2025
GrantMay 1, 2023
Series BApr 6, 2022
Growth Equity
Jan 6, 2021

Key People

Founding team and executive leadership

Doug Evans

President & CEO

Executive Team

Rosemarie Dhavale

Chief Financial Officer

Executive Team

Viral Thakkar

Chief Operating Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 28, 2026

    $12M raised in Seed Round.

  • Apr 1, 2025

    $10M raised from WJFS

Lungpacer Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lungpacer Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lungpacer Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersExton, Pennsylvania
Employee Range59
Year Founded2009
Last FundingApr 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?